Sort
48,018 grants matching “immunotherapy”
Immunotherapeutic targeting of gangliosides in Ewing Sarcoma
$755,393Robbie G. Majzner · Dana-Farber Cancer Inst · U01 · FY2024 · CA
Cyclic Flow Cytometry for Ultra-High Marker Single-Cell Analysis
$755,367Sheldon J.j. Kwok · Lase Innovation Inc. · R44 · FY2022 · GM
Human Immune Responses to Tumor Antigens for Cancer Vaccine Development
$755,122Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Phosphorylatable Monoclonal Antibodies for Tumor Therapy
$755,009Pbl Biomedical Laboratories · R44 · FY2002 · CA
Characterizing the therapeutic efficacy of CD8 T cell responses induced by the IL-15 superagonist ALT-803
$754,981Shelby L Oconnor · University Of Wisconsin-Madison · R01 · FY2023 · AI
Development of Recombinant Toxins to Treat Hematologic Malignancies
$754,944Robert Kreitman · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Mechanisms and Optimal Combinations of Cisplatin Chemotherapy for Head and Neck Squamous Cell Carcinoma
$754,861Nicole Schmitt · National Institute On Deafness And Other Communication Disorders · ZIA · FY2016 · DC
Hydrogel microparticle technology for high-throughout screening of chimeric antigen receptor-T cells based on single cell effector function
$754,792Joseph De Rutte · Partillion Bioscience Corporation · R44 · FY2023 · GM
New therapeutics for Shiga toxin-E. coli disease.
$754,653Tom G Obrig · University Of Maryland Baltimore · U01 · FY2008 · AI
Mechanisms and Therapeutic Targeting of T cell Regulation in Heart Allograft Recipient Monkeys
$754,653Mohamed B Ezzelarab · University Of Pittsburgh At Pittsburgh · U01 · FY2024 · AI
Temporal Transcriptomics in Hospitalized COVID-19 Patients from Disparately Impacted Ancestral Groups for Therapeutic Discovery
$754,597Douglas Jay Perkins · University Of New Mexico Health Scis Ctr · R01 · FY2022 · AI
Discovery of novel tau proteoforms as biomarker candidates for AD and PSP
$754,586Jeffrey Dage · Indiana University Indianapolis · R01 · FY2025 · AG
Development of therapeutic chemokine-based formulations
$754,563Arya Biragyn · National Institute On Aging · ZIA · FY2014 · AG
Enhancing B7-H3-CAR T cell therapy for pediatric solid tumors
$754,519Christopher C. Derenzo · St. Jude Children'S Research Hospital · R01 · FY2025 · CA
Discovery of host genetic elements affecting response to immune checkpoint inhibitors
$754,511Edison Tak-Bun Liu · Jackson Laboratory · R01 · FY2025 · CA
Vascular macrophages and T cells in atherosclerosis
$754,375Klaus F. Ley · Augusta University · R35 · FY2024 · HL
BALTIMORE PEDIATRIC AIDS CLINICAL TRIALS GROUP
$754,374Johns Hopkins University · U01 · FY2000 · AI
Modulation of B Cell Responses in Autoimmunity
$754,006Duke University · U19 · FY2004 · AI
Molecular Allergy
$753,852Geoffrey Mueller · National Institute Of Environmental Health Sciences · ZIA · FY2023 · ES
Characterizing the therapeutic efficacy of CD8 T cell responses induced by the IL-15 superagonist ALT-803
$753,619Shelby L Oconnor · University Of Wisconsin-Madison · R01 · FY2021 · AI
Targeting Neuroblastoma with armed T cells
$753,575Lawrence G Lum · Wayne State University · R01 · FY2015 · CA
Identification and eliminationof HIV reservoirs in oral lymphoid tissues by engineered NK cells.
$753,568Jonathan Karn · Case Western Reserve University · R01 · FY2018 · DE
Activated NK CAR Cells to Cure HIV
$753,478Pamela J Skinner · University Of Minnesota · R01 · FY2023 · AI
Activated NK CAR Cells to Cure HIV
$753,478Pamela J Skinner · University Of Minnesota · R01 · FY2022 · AI
Activated NK CAR Cells to Cure HIV
$753,478Pamela J Skinner · University Of Minnesota · R01 · FY2024 · AI